Biocryst Pharma Inc - BCRX - stock price prediction, stock price target, analyst ratings from 10 analysts

Biocryst Pharma Inc has a share price target of US$ 21, revenue growth forecast of -25.6%, and profit growth estimate of -79.3% for FY26, based on top 10 analyst calls.